Workflow
信用债热点事件系列:“科创债”新政首周,有何特征?
Hua Yuan Zheng Quan·2025-05-21 01:18
  1. Report Industry Investment Rating The report does not mention the industry investment rating. 2. Core View of the Report In the context of current policy support and high market attention, combined with the diversified innovation of relevant policies and issuance terms of science - innovation bonds, the credit risk of science - innovation bonds is generally low in the short term. Currently, the issuance of science - innovation bonds has not reached a large scale, especially the issuance scale of science - innovation bonds of equity investment institutions is relatively small. It is recommended to select issuers with good qualifications and pay attention to the bidding opportunities for the primary issuance of their science - innovation bonds. Structurally, it is advisable to focus on science - innovation bonds with innovative terms such as conversion options and coupon rate linkage, or those with corresponding credit risk mitigation certificates created by third - party credit enhancement institutions, to seek excess returns from the liquidity premium at the initial stage of the bonds' listing [3][28]. 3. Summary According to the Directory 3.1 High - rated Central State - owned Enterprises Predominate, and Equity Investment Institutions' Issuance Has Not Reached a Large Scale - Expansion of Issuer Scope: The "Notice No. 8" expands the scope of science - innovation bond issuers, including financial institutions, technology - based enterprises, and equity investment institutions. Exchanges and the National Association of Financial Market Institutional Investors (NAFMII) have also adjusted their regulations on issuer types and scopes [6]. - Characteristics of Issuers in the First Week: Banks are the main issuers of science - innovation bonds in the first week after the new policy, mainly large national and joint - stock banks. The issuers of science - innovation bonds are characterized by high ratings and being central or local state - owned enterprises. From May 6 to May 16, 2025, the cumulative issuance scale of AAA - rated issuers was 147.9 billion yuan, accounting for 83.39% of the total scale; the cumulative issuance scale of central and local state - owned enterprises was 168.6 billion yuan, accounting for 95.04% of the total scale [3][11]. - Issuance Status of Equity Investment Institutions: As of May 16, 2025, the issuance scale of equity investment institutions' science - innovation bonds has not reached a large scale. A total of 10 bonds were issued, with a cumulative issuance scale of 420 million yuan. However, many equity investment institutions' science - innovation bonds are in the application or registration process. It is expected that the issuance scale of equity investment institutions' science - innovation bonds will increase significantly in the future [14]. 3.2 The New Policy on "Science - innovation Bonds" Relaxes the Restrictions on the Use of Raised Funds - Exchange Regulations: Previously, the proportion of raised funds invested in the science - innovation field by certain types of issuers should be no less than 70%. The new policy does not set specific requirements for the proportion of funds invested by newly - supported financial institutions and equity investment institutions. It also supports equity investment institutions in using raised funds for the establishment and expansion of private equity investment funds [18]. - NAFMII Regulations: Previously, at least 50% of the raised funds of use - specific science - innovation notes should be used to support the science - innovation field. The new policy only requires that at least 50% of the raised funds of equity investment institutions' science - innovation bonds be invested in science - innovation enterprises. It also supports technology - based enterprises to issue science - innovation bonds through their parent companies [18][19]. - Use of Raised Funds by Different Issuers: Banks mainly use the raised funds to issue loans in the science - innovation field, which helps guide long - term funds into the real science - innovation sector. Equity investment institutions mainly use the funds to invest in private equity investment funds, subscribe for fund shares directly, or replace their own capital contributions within one year, providing low - cost and long - term capital support for venture capital institutions [3][21]. 3.3 Creation of Diversified Innovative Terms - Exchange and NAFMII Initiatives: Exchanges and the NAFMII encourage issuers to innovate in terms of issuance methods, term structures, interest rate determination, and other aspects, and support the setting of innovative terms such as expected income pledge guarantee, intellectual property pledge guarantee, and convertible to equity [24]. - Existing Innovative Terms: The innovative terms of issued science - innovation bonds mainly include conversion options, over - issuance rights, etc. Some credit enhancement institutions have also created credit risk mitigation certificates (CRMW) for some issued science - innovation bonds. These terms can attract different types of investors, flexibly determine the issuance scale, enhance bond attractiveness, and reduce investors' risks [3][25]. 3.4 Investment Suggestions Select issuers with good qualifications and pay attention to the bidding opportunities for the primary issuance of their science - innovation bonds. Structurally, focus on science - innovation bonds with innovative terms or third - party credit enhancement [3][28].